Chen R - Search Results

1

Survival effect of different lymph node staging methods on ovarian cancer: An analysis of 10 878 patients.

Wang J, Li J, Chen R, Lu X. Wang J, et al. Among authors: chen r. Cancer Med. 2018 Sep;7(9):4315-4329. doi: 10.1002/cam4.1680. Epub 2018 Aug 18. Cancer Med. 2018. PMID: 30121963 Free PMC article.

2

[Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].

Chen R, Zhu T, Yu H, Zhu J, Lu X. Chen R, et al. Zhonghua Fu Chan Ke Za Zhi. 2014 Apr;49(4):254-9. Zhonghua Fu Chan Ke Za Zhi. 2014. PMID: 24969331 Chinese.

3

The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis.

Li J, Li S, Chen R, Yu H, Lu X. Li J, et al. Among authors: chen r. J Ovarian Res. 2015 Aug 6;8:54. doi: 10.1186/s13048-015-0181-z. J Ovarian Res. 2015. PMID: 26242216 Free PMC article.

4

Increased risk of poor survival in ovarian cancer patients with high expression of SNAI2 and lymphovascular space invasion.

Li J, Li S, Chen R, Lu X. Li J, et al. Among authors: chen r. Oncotarget. 2017 Feb 7;8(6):9672-9685. doi: 10.18632/oncotarget.14192. Oncotarget. 2017. PMID: 28039463 Free PMC article. Review.

5

The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.

Li J, Wang J, Chen R, Bai Y, Lu X. Li J, et al. Among authors: chen r. Oncotarget. 2017 Feb 28;8(9):15621-15631. doi: 10.18632/oncotarget.14919. Oncotarget. 2017. PMID: 28152503 Free PMC article.

6

Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.

Wang J, Li J, Chen R, Lu X. Wang J, et al. Among authors: chen r. Eur J Surg Oncol. 2018 Jul;44(7):1054-1061. doi: 10.1016/j.ejso.2018.03.027. Epub 2018 Apr 6. Eur J Surg Oncol. 2018. PMID: 29705285

7

Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis.

Li J, Yue H, Wang X, Chen R, Lu X. Li J, et al. Among authors: chen r. Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:164-169. doi: 10.1016/j.ejogrb.2019.05.023. Epub 2019 May 20. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31136884

8

Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer.

Yue H, Wang J, Chen R, Hou X, Li J, Lu X. Yue H, et al. Among authors: chen r. BMC Cancer. 2019 Dec 30;19(1):1266. doi: 10.1186/s12885-019-6470-y. BMC Cancer. 2019. PMID: 31888563 Free PMC article.

9

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.

Zhu T, Chen R, Wang J, Yue H, Lu X, Li J. Zhu T, et al. Among authors: chen r. Cancer Cell Int. 2020 Jun 18;20:257. doi: 10.1186/s12935-020-01344-2. eCollection 2020. Cancer Cell Int. 2020. PMID: 32565741 Free PMC article.

10

The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.

Wang J, Chen R, Li J, Lu X. Wang J, et al. Among authors: chen r. Arch Gynecol Obstet. 2020 Dec;302(6):1441-1450. doi: 10.1007/s00404-020-05772-3. Epub 2020 Sep 4. Arch Gynecol Obstet. 2020. PMID: 32888090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,110 results

Search Page

Filters